We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 864

Intellectual Property Weekly Abstracts Bulletin Week of August 14, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • August 16 2017

Default judgment for copyright infringement upheld by Court as no evidence found for out-of-court settlement Benchmuel v. Gags N Giggles, 2017 FC 720


Intellectual Property Weekly Abstracts Bulletin Week of August 7, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • August 9 2017

Appeal of registrar's expungement decision granted; GO PHONE Services not dependent on the network that hosts them AT&T Intellectual Property II, L.P


Intellectual Property Weekly Abstracts Bulletin Week Of July 31, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • August 2 2017

This is an appeal of the Federal Court’s decision allowing Gilead’s claim to invalidate Idenix’s ‘191 Patent on the grounds of insufficient disclosure


Intellectual Property Weekly Abstracts - July 17, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 19 2017

Proposed prosecution bar in addition to protective order denied due to insufficient evidence Abbvie Corporation v. Samsung Bioepis Co., Ltd., 2017 FC


Intellectual Property Weekly Abstracts Bulletin Week of July 17, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 19 2017

In this case, AbbVie brought an application against Samsung pursuant to the NOC Regulations. The parties agreed that a protective order was needed


Intellectual Property Weekly Abstracts Bulletin Week of July 10, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 12 2017

Motion on additional read-ins allowed in part; hearsay excluded Excalibre Oil Tools Ltd. v. Advantage Products Inc., 2016 FC 1130 In this patent


Intellectual Property Weekly Abstracts Bulletin Week of July 3, 2017
  • Borden Ladner Gervais LLP
  • Canada
  • July 5 2017

Supreme Court of Canada invalidates the promise doctrine AstraZeneca Canada Inc. v. Apotex Inc., 2017 SCC 36 Drug: esomeprazole In this decision, the


Costs thrown away as a consequence of the cancellation of the initial hearing awarded at the upper end of Column IV
  • Borden Ladner Gervais LLP
  • Canada
  • July 3 2017

Following redetermination (see 2017 FC 526, our summary here), the parties were unable to agree on Pfizer’s costs. In its judgment, the Court had


Motion for bifurcation of liability issues, as well as counterclaim for section 8 damages, dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • July 3 2017

The Court dismissed the Plaintiffs’ motion for a bifurcation order requesting that liability issues in this infringement action be tried separately


Supreme Court of Canada invalidates the promise doctrine
  • Borden Ladner Gervais LLP
  • Canada
  • July 3 2017

In this decision, the Supreme Court of Canada (SCC) overturned the decision of the Federal Court of Appeal (FCA), and held the patent to be valid and